FDA Inspection
Kaiser Permanente of the Mid-Atlantic States IRB #7Kaiser Permanente of the Mid-Atlantic States IRB #7 – FDA Inspection, Feb 26, 2024
Record Details
This FDA Inspection record concerns Kaiser Permanente of the Mid-Atlantic States IRB #7, with an inspection on February 26, 2024, covering drugs.
- Inspection Date
- February 26, 2024
- Product Type
- Drugs
View Company Profile
ID · 9411ccfd-8d26-4c76-b589-f6c782b26581
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1232973
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Kaiser Permanente of the Mid-Atlantic States IRB #7
1| Date | Classification | Office | Project area |
|---|---|---|---|
| October 10, 2017 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Kaiser Permanente of the Mid-Atlantic States IRB #7
- FDA Inspection 1028527 - 2017-10-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.